Insider · CIK 0001800670
Barbara Weber
Files at TNGX (Tango Therapeutics, Inc.). First filing Feb 4, 2026, latest Feb 4, 2026.
Barbara Weber files SEC Form 4 as chair and director at TNGX (Tango Therapeutics, Inc.). Since Feb 4, 2026, Barbara Weber has reported 0 open-market buys worth $0 and 1 open-market sell worth $374k, the latest filed on Feb 4, 2026.
A track record needs three past buys with six months of prices behind them; Barbara Weber has 0, so none is measured yet.
The newest scored trade: sold $374k of TNGX on Feb 3, 2026, filed Feb 4, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $374k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNGX: Tango Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Tango Therapeutics, Inc. | $374k 30,519 shares | -2% | +1041% from low-4% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | TNGX Tango Therapeutics, Inc. | AGrant or award Common Stock | +37,522 | $0.00 | $0 | 1,659,773 | Feb 4, 2026 |
| Feb 3, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -30,186 | $12.26 | $370k | 1,629,587 | Feb 4, 2026 |
| Feb 3, 2026 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -333 | $12.90 | $4,295 | 1,629,254 | Feb 4, 2026 |
| Feb 2, 2026 | TNGX Tango Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +222,132 | $0.00 | $0 | 222,132 | Feb 4, 2026 |
Questions about Barbara Weber
Answered from the filings on this page, as of the latest one.
Is Barbara Weber buying or selling?
In the last 12 months Barbara Weber reported 0 open-market buys worth $0 and 1 open-market sell worth $374k on SEC Form 4; the latest was sold $374k of TNGX on Feb 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Barbara Weber's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Barbara Weber has 0.
Where does Barbara Weber file Form 4?
Barbara Weber has filed Form 4 at TNGX (Tango Therapeutics, Inc.) as Director, Executive Chair. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.